Morris C - Search Results

1

BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline.

Lane R, He Y, Morris C, Leverenz JB, Emre M, Ballard C. Lane R, et al. Among authors: morris c. Mov Disord. 2009 Feb 15;24(3):392-400. doi: 10.1002/mds.22357. Mov Disord. 2009. PMID: 19006190

2

APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.

Ballard CG, Morris CM, Rao H, O'Brien JT, Barber R, Stephens S, Rowan E, Gibson A, Kalaria RN, Kenny RA. Ballard CG, et al. Among authors: morris cm. Neurology. 2004 Oct 26;63(8):1399-402. doi: 10.1212/01.wnl.0000141851.93193.17. Neurology. 2004. PMID: 15505155

3

Dementia with Lewy bodies.

McKeith IG, Burn DJ, Ballard CG, Collerton D, Jaros E, Morris CM, McLaren A, Perry EK, Perry R, Piggott MA, O'Brien JT. McKeith IG, et al. Semin Clin Neuropsychiatry. 2003 Jan;8(1):46-57. doi: 10.1053/scnp.2003.50006. Semin Clin Neuropsychiatry. 2003. PMID: 12567332 Review.

4

The k variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients.

Ballard C, Morris C, Kalaria R, McKeith I, Perry R, Perry E. Ballard C, et al. Among authors: morris c. Dement Geriatr Cogn Disord. 2005;19(5-6):357-60. doi: 10.1159/000084705. Epub 2005 Mar 30. Dement Geriatr Cogn Disord. 2005. PMID: 15802910

5

Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.

Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, Morris CM, O'Brien JT. Barber R, et al. Among authors: morris cm. Arch Neurol. 1999 Aug;56(8):961-5. doi: 10.1001/archneur.56.8.961. Arch Neurol. 1999. PMID: 10448801

6

The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease.

Ballard C, O'Brien J, Morris CM, Barber R, Swann A, Neill D, McKeith I. Ballard C, et al. Among authors: morris cm. Int J Geriatr Psychiatry. 2001 May;16(5):499-503. doi: 10.1002/gps.381. Int J Geriatr Psychiatry. 2001. PMID: 11376466

7

Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.

Holmes C, Ballard C, Lehmann D, David Smith A, Beaumont H, Day IN, Nadeem Khan M, Lovestone S, McCulley M, Morris CM, Munoz DG, O'Brien K, Russ C, Del Ser T, Warden D. Holmes C, et al. Among authors: morris cm. J Neurol Neurosurg Psychiatry. 2005 May;76(5):640-3. doi: 10.1136/jnnp.2004.039321. J Neurol Neurosurg Psychiatry. 2005. PMID: 15834019 Free PMC article.

8

Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodies.

Singleton AB, Gibson AM, McKeith IG, Ballard CG, Edwardson JA, Morris CM. Singleton AB, et al. Among authors: morris cm. Neurosci Lett. 2001 Apr 27;303(1):33-6. doi: 10.1016/s0304-3940(01)01694-9. Neurosci Lett. 2001. PMID: 11297817

9

Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease.

Ballard C, Massey H, Lamb H, Morris C. Ballard C, et al. Among authors: morris c. J Neurol Neurosurg Psychiatry. 1997 Aug;63(2):273-4. doi: 10.1136/jnnp.63.2.273b. J Neurol Neurosurg Psychiatry. 1997. PMID: 9285479 Free article. No abstract available.

10

Is apolipoprotein e4 associated with cognitive decline in depression?

Jackson EJ, Rajah S, Morris C, Ballard C, Thomas AJ, O'Brien JT. Jackson EJ, et al. Among authors: morris c. Int J Geriatr Psychiatry. 2001 Apr;16(4):436-7. doi: 10.1002/gps.347. Int J Geriatr Psychiatry. 2001. PMID: 11333434 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,285 results

Search Page